Replies to post #81308 on Vivos Inc (RDGL)

[Multi_Pennies]

we were at around .06 per share when the news came out about the ISOPet formula, 1/30/2018
Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy


and now Proof is in the pudding with results.
we are sitting at .02 cents per share rounded off. Did I miss something or did all the doubt about ISOPET just come true.


Richland, WA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC PINK: RDGL) first therapy to canine treat soft tissue sarcoma is successful